Children with psoriasis and COVID‐19: factors associated with an unfavourable COVID‐19 course, and the impact of infection on disease progression (Chi‐PsoCov registry)Jinane Zitouni, Anna Belloni Fortina, Alain Beauchet et al.|Journal of the European Academy of Dermatology and Venereology|2022Cited by 14
Effectiveness and Safety of Adalimumab, Etanercept and Ustekinumab for Severe Psoriasis in Children Under 12 Years of Age: A French-Italian Daily Practice Cohort (BiPe Jr)Jinane Zitouni, Alain Beauchet, R. Curmin et al.|Pediatric Drugs|2022Cited by 13